BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $254,000 | -20.9% | 5,023 | 0.0% | 0.02% | +6.2% |
Q1 2022 | $321,000 | -18.9% | 5,023 | +35.8% | 0.02% | -30.4% |
Q4 2021 | $396,000 | +0.3% | 3,700 | -3.7% | 0.02% | 0.0% |
Q3 2021 | $395,000 | +16.9% | 3,842 | 0.0% | 0.02% | +9.5% |
Q2 2021 | $338,000 | +3.7% | 3,842 | +14.4% | 0.02% | -8.7% |
Q1 2021 | $326,000 | +43.6% | 3,357 | +65.6% | 0.02% | +21.1% |
Q4 2020 | $227,000 | +7.6% | 2,027 | -10.8% | 0.02% | -20.8% |
Q3 2020 | $211,000 | -72.3% | 2,272 | -76.1% | 0.02% | -61.9% |
Q4 2019 | $763,000 | +43.4% | 9,526 | +31.6% | 0.06% | +34.0% |
Q3 2019 | $532,000 | +6.0% | 7,238 | +36.0% | 0.05% | 0.0% |
Q2 2019 | $502,000 | +60.4% | 5,323 | +35.9% | 0.05% | +62.1% |
Q1 2019 | $313,000 | -51.2% | 3,916 | -67.1% | 0.03% | -52.5% |
Q4 2018 | $642,000 | -0.9% | 11,914 | +43.5% | 0.06% | +15.1% |
Q3 2018 | $648,000 | +213.0% | 8,300 | +268.4% | 0.05% | +178.9% |
Q1 2018 | $207,000 | – | 2,253 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
SIB LLC | 65,151 | $6,335,000 | 3.72% |
CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |